In CKD, trimethylamine N-oxide (TMAO), a gut microbiota-dependent product, induced NLRP3 inflammasome activation and NF-κB signals which promotes calcification in VSMCs [11]. This evidence concerns the gene NFKB1 and chronic kidney disease.